A chemist based at the University of Copenhagen has just taken out a patent for a drug that can make previously multidrug-resistant bacteria responsive to antibiotics once again.
Jørn Bolstad and his chemist colleagues hope that the substance will soon be able to tackle the tremendous problems associated with multidrug resistant tuberculosis (MDR-TB). But first, they need to find investors interested in getting the substance onto the market.
Before the development of penicillin, people dropped like flies in response to minor infections: in the lungs, in small cuts. Even pimples could grow to boils that killed. But one of the main killers prior to the discovery of antibiotics was tuberculosis.
The deadly infectious disease that typically affects the lungs has returned. It has developed a resistance to the majority of antibiotics that would otherwise kill the tuberculosis bacteria. Currently, the disease does not pose an imminent threat to Denmark or the West. However, resistant strains of the bacteria are nearing the region’s borders. This is one of the reasons why doctors around the world are busy trying to solve the problem of drug resistance.
The bacteria shed killing substances
While those bacteria that have developed a resistance remain vulnerable to antibiotics, they have developed an ability to shed bacteria killing substances before any damage is done to them. Colloquially, this is referred to as pooping the substance out, but the scientific formulation is that these bacteria activate an efflux pump.
Jørn Bolstad Christensen has isolated a substance able to block the efflux pump so that an antibiotic remains in bacteria until the bacteria dies.
You could say that we cure bacteria of their resistance, and slay them with antibiotics, explains Associate Professor Jørn Bolstad Christensen.
From antipsychotic to killing bacteria
Working with doctors Jette Kristiansen from the University of Southern Denmark and Oliver Hendricks from the King Christian X’s Hospital for Rheumatic Diseases in Gråsten, Denmark, Jørn Bolstad Christensen discovered that Thioridazin, an antipsychotic drug, was able to kill bacteria without any noticeably harmful effects upon humans. Still, the chemists had an idea that could make the substance more benign.
We now have a substance that is able to block the bacteria’s efflux pump. At very most, recipients of the medication may become slightly sluggish. This is also because very small doses are needed to affect the bacteria, says Jørn Bolstad Christensen.
Researchers hope for quick approval
Because Thioridazin is an approved drug, the research team hopes that the new anti-resistance medication, JEK 47, will be approved without going through the entire process that new pharmaceuticals are typically subjected to. If this is the case, JEK 47 will most likely be a cheap medication that a pharmaceuticals manufacturer could release quickly. However if an investor does not show interest, Christensen is certain about his next step.
The Latest on: Antibiotic resistance
via Google News
The Latest on: Antibiotic resistance
- Why the Meat We Eat Is an Antibiotic-Resistance Threaton March 2, 2021 at 4:12 pm
Overuse of these medicines in livestock can affect humans, too.
- Proposed UTI Vaccine Could End Improper Antibiotic Useon March 2, 2021 at 10:56 am
Although it's still in development, a vaccine against current and future urinary tract infections could also wipe out other problems, such as women being given the wrong antibiotic or given ...
- Optimizing disinfection to prevent spread of antibiotic resistance in wastewateron March 2, 2021 at 9:32 am
Antibiotic-resistant bacteria have become a global threat today, owing in part to the efficiency with which resistance spreads among them. Some of this spread happens in waterbodies--and our ...
- Spread of Antibiotic Resistance in Wastewater (image)on March 2, 2021 at 9:32 am
Antibiotic-resistant bacteria, such as Staphylococcus aureus, abound in our wastewater effluents where they could be spreading the resistance gene to other (pathogenic) bacteria. Scientists have now b ...
- Popeyes Announces Plans To Remove Artificial Ingredients, Antibioticson March 2, 2021 at 6:00 am
Popeyes announced new food quality and sustainability commitments as part of a 5-year plan facilitated by parent company Restaurant Brands International. Those commitments extend from its food to its ...
- Researchers explore early stages of ribosome formation to identify new targets for antibioticson March 1, 2021 at 9:50 pm
Ribosome formation is viewed as a promising potential target for new antibacterial agents. Researchers from Charité - Universitätsmedizin Berlin have gained new insights into this multifaceted process ...
- Antibiotic resistome from the One-Health perspective: understanding and controlling antimicrobial resistance transmissionon March 1, 2021 at 3:20 am
A deeper understanding of the interplay between the human microbiome and micro-organisms present in animals and the environment will be critical for controlling antimicrobial resistance. Researchers ...
- Many women getting wrong antibiotic for UTI, study sayson February 28, 2021 at 4:00 pm
Inappropriate use of antibiotics has fueled a surge in drug-resistant bacteria. These germs can spread and cause infections that common antibiotics are unable to cure. RELATED Hormone replacement ...
- Searching for novel targets for new antibioticson February 28, 2021 at 4:00 pm
Ribosome formation is viewed as a promising potential target for new antibacterial agents. Researchers from Charité - Universitätsmedizin Berlin have gained new insights into this multifaceted process ...
- Commonly used sweeteners may promote antibiotic resistanceon February 28, 2021 at 12:14 pm
Researchers in Australia have conducted a study showing that commonly used nonnutritive sweeteners can promote the spread of antibiotic-resistant genes in the intestine.
via Bing News